
    
      A Randomized, open label, single dose, crossover phase I clinical study to compare the
      pharmacokinetic profiles and bactericidal activity of Zabofloxacin 183mg, 367mg and
      Levofloxacin 250mg after oral administration in healthy volunteer
    
  